YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice

This publication has 34 references indexed in Scilit:

• Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
  BMJ, 1994
• Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms
  Blood, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• In vivo effect of a thrombin-like enzyme on platelet plug formation induced in mesenteric microvessels of mice
  Thrombosis Research, 1994
• Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins
  Thrombosis Research, 1993
• Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs
  Progress in Cardiovascular Diseases, 1992
• Antiplatelet Agents in the Prevention and Therapy of Thrombosis
  Annual Review of Medicine, 1992
• The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated platelets
  Thrombosis Research, 1991
• Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance
  Journal of the American College of Cardiology, 1990
• Platelets and Thrombolytic Therapy
  New England Journal of Medicine, 1990